Maritz Hires Chief Behavioral Officer – Daily Research News Online

In the US, research-led sales and marketing services company Maritz has appointed Charlotte Blank as Chief Behavioral Officer (CBO), tasked with leading its thought leadership, research, and the application of behavioral science.

The firm is based in St. Louis and its portfolio of services includes market and customer research; customer loyalty, sales incentives, employee rewards and recognition programs; and meeting, event and travel incentive services. Blank (pictured) previously led neuromarketing, social media and global branding initiatives during her ten years in the media and automotive industries, which included stints at Turner Broadcasting and General Motors. In her new role, she will also develop Maritz' network of academic partners and focus on opportunities for field research with these contacts and with clients.

CEO and Chairman Steve Maritz comments: 'At our core, we're a behavior company. The scientific study of human behavior is a central component of Maritz' DNA, and ingrained in the design of our client solutions. With Charlotte as our CBO, we can emphasize to the market and our clients the role behavioral science plays in powering our solutions and improving their business performance'.

Web site: http://www.maritz.com .

See more here:
Maritz Hires Chief Behavioral Officer - Daily Research News Online

Novel gene editing approach to cancer treatment shows promise in mice – Medical Xpress

May 1, 2017 Killer T cells surround a cancer cell. Credit: NIH

A novel gene therapy using CRISPR genome editing technology effectively targets cancer-causing "fusion genes" and improves survival in mouse models of aggressive liver and prostate cancers, University of Pittsburgh School of Medicine researchers report in a study published online today in Nature Biotechnology.

"This is the first time that gene editing has been used to specifically target cancer fusion genes. It is really exciting because it lays the groundwork for what could become a totally new approach to treating cancer," explained lead study author Jian-Hua Luo, M.D., Ph.D., professor of pathology at Pitt's School of Medicine and director of its High Throughput Genome Center.

Fusion genes, which often are associated with cancer, form when two previously separate genes become joined together and produce an abnormal protein that can cause or promote cancer.

Luo and his team had previously identified a panel of fusion genes responsible for recurrent and aggressive prostate cancer. In a study published earlier this year in the journal Gastroenterology, the team reported that one of these fusion genes, known as MAN2A1-FER, also is found in several other types of cancer, including that of the liver, lungs and ovaries, and is responsible for rapid tumor growth and invasiveness.

In the current study, the researchers employed the CRISPR-Cas9 genome editing technology to target unique DNA sequences formed because of the gene fusion. The team used viruses to deliver the gene editing tools that cut out the mutated DNA of the fusion gene and replaced it with a gene that leads to death of the cancer cells. Because the fusion gene is present only in cancer cells, not healthy ones, the gene therapy is highly specific. Such an approach could come with significantly fewer side effects when translated to the clinic, which is a major concern with other cancer treatments such as chemotherapy.

To conduct the study, the researchers used mouse models that had received transplants of human prostate and liver cancer cells. Editing the cancer fusion gene resulted in up to 30 percent reduction in tumor size. None of the mice exhibited metastasis and all survived during the eight-week observation period. In contrast, in control mice treated with viruses designed to cut out another fusion gene not present in their tumors, the tumors increased nearly 40-fold in size, metastasis was observed in most animals, and all died before the end of the study.

The new findings suggest a completely new way to combat cancer. "Other types of cancer treatments target the foot soldiers of the army. Our approach is to target the command center, so there is no chance for the enemy's soldiers to regroup in the battlefield for a comeback," said Luo.

Another advantage over traditional cancer treatment is that the new approach is very adaptive. A common problem that renders standard chemotherapies ineffective is that the cancer cells evolve to generate new mutations. Using genome editing, the new mutations could be targeted to continue fighting the disease, Luo noted.

In the future, the researchers plan to test whether this strategy could completely eradicate the disease rather than induce the partial remission observed in the current study.

Explore further: A new approach to target an 'undruggable' prostate cancer driver

More information: Targeting genomic rearrangements in tumor cells through Cas9-mediated insertion of a suicide gene, Nature Biotechnology (2017). nature.com/articles/doi:10.1038/nbt.3843

New research suggests a novel strategy to target a genetic anomaly that occurs in half of all prostate cancers.

Using the gene-editing system known as CRISPR, MIT researchers have shown in mice that they can generate colon tumors that very closely resemble human tumors. This advance should help scientists learn more about how the disease ...

Researchers from Memorial Sloan Kettering Cancer Center (MSK) have harnessed the power of CRISPR/Cas9 to create more-potent chimeric antigen receptor (CAR) T cells that enhance tumor rejection in mice. The unexpected findings, ...

Angiosarcoma is a malignant cancer of the endothelial cells of blood or lymphatic vessels. Cutaneous angiosarcoma, a form of skin cancer, commonly occurs on the scalp of elderly people and can rapidly metastasize to the liver, ...

A genetic discovery out of the University of Pittsburgh School of Medicine is leading to a highly accurate test for aggressive prostate cancer and identifies new avenues for treatment.

A novel gene therapy using CRISPR genome editing technology effectively targets cancer-causing "fusion genes" and improves survival in mouse models of aggressive liver and prostate cancers, University of Pittsburgh School ...

Researchers have found a genetic explanation for how smoking can lead to coronary heart disease (CHD). Many people have a protective gene type that reduces levels of an enzyme connected to artery-clogging fatty plaques and ...

The Tibetan people have inherited variants of five different genes that help them live at high altitudes, with one gene originating in the extinct human subspecies, the Denisovans. Hao Hu and Chad Huff of the University of ...

Physical activity can reduce the weight-gaining effects of the genetic variant that carries the greatest risk of obesity, report Mariaelisa Graff of the University of North Carolina at Chapel Hill, Tuomas Kilpelinen of ...

Researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) have identified a previously unrecognized step in stem cell-mediated muscle regeneration. The study, published in Genes and Development, provides new ...

An international study based at UT Southwestern Medical Center revealed a striking genetic-environmental interaction: Obesity significantly amplifies the effects of three gene variants that increase risk of nonalcoholic fatty ...

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Read the original post:
Novel gene editing approach to cancer treatment shows promise in mice - Medical Xpress

This Founder is using Synbio to Revolutionize Genetic Medicine – Labiotech.eu (blog)

Oxford Genetics founder and CEO Ryan Cawood told me about his companys improvements to DNA design for better biologicals.

Last month at Synbiobeta, I caught up with Ryan Cawood, who created one of the most successful synthetic biology companies around, Oxford Genetics. Our direction actually took off from this conference, he told me. We saw that the cost of DNA synthesis is going to be driven down, so this was not a market for us to compete in.

Instead of focusing on making DNA engineering cheaper, Cawood decided to explore how to improve the quality of its products. Specific inspiration came in the form of frustration as he was trying to finish his PhD in genetics at Oxford University

I was making gene therapy plasmids, and they were increasingly hard to test because we just couldnt make them. They were 50 to 100 kilobases for different viruses with no standardization one section camefrom Spain, one section from the US, and one from the back of the freezerit was a sort of genetic car crash, as my PI, Len Seymour, called it.

As a company, we set out to improve this by focusing on DNA design we now help other companies working on therapeutics develop them better with SnapFast, a lego-like core DNA system.

In 2011, I formed the company by taking out bank loan. Then I negotiated a lab bench from local company in return for gene engineering for them. Finally, I built a website. Ive since obtained seven grants and connected with solid investors. Mercia Technologies has invested three times now the first time was in 2013 and on this next round, someone else will probably come in as well.

Len, my former lab PI, is still on the board as one of the cofounders. He was actually involved in founding two biotech companies before hand, one for oncolytic viruses (PsiOxus Therapeutics) and one for protein expression (The Native Antigen Company).

Cawoods lightning talk at Synbiobeta: fromsynthetic biology, Oxford Genetics is building up to improve biological drugsto reachpersonalised versions.

Well, our trajectory and plan was to build better DNA tech for the design and synthesis to discover and manufacture biologicals better. Fundamentally, youre always trying to build a tool to develop these better.

What Id like to see from the field is a major advancement of human therapeutics. There are four major challenges in biological development that were working to address: discovery, design, production and delivery basically every step.

We think Snapfast DNA will improve all of them because DNA is an integral part of each. So, we can absolutely use synbio to improve cell and gene therapies and biologics.

People who work in the area think of synbio as making things in algae, or making new genetic circuits etc, but dont necessarily see consequences for human health. The field has a huge role to play in tying the genetics of an individual human to a therapeutic treatment based on DNA. At the moment, there is no such pairing were a long way from that, but with synbio well get there.

We take a sort of blunt hammer approach now: its very inefficient therapeutically, and its a very inefficient use of government funds. By funding a better understanding of people, youll see significant gains intreatmentefficiencies.

The current approach is far too retrospective at the moment: we give a drug and then try to figure out why it worked in some people afterwards, or we just carry on giving it everyone knowing only a few people will benefit, in the future I hope we can predict efficacy and act upon that calculation.

Im still very much motivated by the therapeutic side of synthetic biology. Not everyone working at the company has a background in human genetics some come from working on archaea, but they all are oriented towards working towards therapeutics. Even my PA has first class degree in genetics.

DNA foundries are all the rage in synbio now, but we were much more interested in biology than physical manufacture that is, were much more focused on end goal versus how you get there. This thinking has changed the company a lot: instead of just making things, were designing things.

Images from Oxford Genetics,author at Synbiobeta, 04 April 2017, Mercia, & Sergei Drozd, Saibarakova Ilona /shutterstock.com

See the original post here:
This Founder is using Synbio to Revolutionize Genetic Medicine - Labiotech.eu (blog)

Global chemical production ends Q1 with slight decline, ACC says – ChemEngOnline

The American Chemistry Councils (ACC; Washington, D.C.; http://www.americanchemistry.com) Global Chemical Production Regional Index (Global CPRI) shows that the first quarter ended on a soft note, with headline global production slipping back 0.1 percent in March, as measured on a three-month moving average (3MMA) basis. This follows a revised 0.1 percent drop in February and a revised 0.4 percent gain in January. During March, chemical production decreased in every region except Africa & the Middle East and Asia-Pacific. The Global CPRI was up 1.3 percent year-over-year (Y/Y) on a 3MMA basis and stood at 108.9 percent of its average 2012 levels in March.

During March, capacity utilization in the global business of chemistry slipped 0.2 percentage points to 78.0 percent. This is off from 79.4 percent last March and is below the long-term (1987-2016) average of 88.7 percent.

Results were mixed on a product basis during March, with gains in agricultural chemicals, bulk petrochemicals & organics, and plastic resins. Considering Y/Y comparisons, growth was strongest in plastic resins followed by coatings and inorganic chemicals.

ACCs Global CPRI measures the production volume of the business of chemistry for 33 key nations, sub-regions, and regions, all aggregated to the world total. The index is comparable to the Federal Reserve Board (FRB) production indices and features a similar base year where 2012=100. This index is developed from government industrial production indices for chemicals from over 65 nations accounting for about 98 percent of the total global business of chemistry. This data are the only timely source of market trends for the global chemical industry and are comparable to the US CPRI data, a timely source of U.S. regional chemical production.

Original post:
Global chemical production ends Q1 with slight decline, ACC says - ChemEngOnline

Animal Biotechnology Technologies, Markets and Companies 2016-2026 – GlobeNewswire (press release)

May 01, 2017 07:30 ET | Source: Research and Markets

Dublin, May 01, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of Jain PharmaBiotech's new report "Animal Biotechnology - Technologies, Markets and Companies" to their offering.

This report describes and evaluates animal biotechnology and its application in veterinary medicine and pharmaceuticals as well as improvement in food production. Knowledge of animal genetics is important in the application of biotechnology to manage genetic disorders and improve animal breeding. Genomics, proteomics and bioinformatics are also being applied to animal biotechnology.

Transgenic technologies are used for improving milk production and the meat in farm animals as well as for creating models of human diseases. Transgenic animals are used for the production of proteins for human medical use. Biotechnology is applied to facilitate xenotransplantation from animals to humans. Genetic engineering is done in farm animals and nuclear transfer technology has become an important and preferred method for cloning animals.There is discussion of in vitro meat production by culture

Biotechnology has potential applications in the management of several animal diseases such as foot-and-mouth disease, classical swine fever, avian flu and bovine spongiform encephalopathy. The most important biotechnology-based products consist of vaccines, particularly genetically engineered or DNA vaccines. Gene therapy for diseases of pet animals is a fast developing area because many of the technologies used in clinical trials humans were developed in animals and many of the diseases of cats and dogs are similar to those in humans.RNA interference technology is now being applied for research in veterinary medicine

Molecular diagnosis is assuming an important place in veterinary practice. Polymerase chain reaction and its modifications are considered to be important. Fluorescent in situ hybridization and enzyme-linked immunosorbent assays are also widely used. Newer biochip-based technologies and biosensors are also finding their way in veterinary diagnostics.

Biotechnology products are approved by the Center for Veterinary Medicine of the FDA. Regulatory issues relevant to animal biotechnology are described.

Approximately 124 companies have been identified to be involved in animal biotechnology and are profiled in the report. These are a mix of animal healthcare companies and biotechnology companies. Top companies in this area are identified and ranked. Information is given about the research activities of 11 veterinary and livestock research institutes. Important 108 collaborations in this area are shown.

Share of biotechnology-based products and services in 2016 is analyzed and the market is projected to 2026.

Key Topics Covered:

Executive Summary

1. Introduction to Animal Biotechnology

2. Application of Biotechnology in Animals

3. A Biotechnology Perspective of Animals Diseases

4. Molecular Diagnostics in Animals

5. Biotechnology-based Veterinary Medicine

6. Research in Animal Biotechnology

7. Animal Biotechnology Markets

8. Regulatory issues

9. Companies Involved in Animal Biotechnology

10. References

For more information about this report visit http://www.researchandmarkets.com/research/6hlgn5/animal

Source: Jain PharmaBiotech

About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Related Articles

Research and Markets Logo

LOGO URL | Copy the link below

Formats available:

See the rest here:
Animal Biotechnology Technologies, Markets and Companies 2016-2026 - GlobeNewswire (press release)

Are you ‘anti-science’ if you resist biotechnology on political or economic grounds? – Genetic Literacy Project

[Editors note: Tess Doezema is a doctoral student at the School for the Future of Innovation in Society at Arizona State University, where she researches biotechnology promise and politics.]

[S]cientists and others offer a picture of a Manichean world divided into those who are for scientific and technological progress and those who are against ita representation of the world that we have been seeing more and more of lately in reports of a war on science. But drawing this line is dangerous. The real problem here is the regulatory process itself, which forces dissent to take the narrow form of challenges to scientific data and methodology and ignores other questions about whats at stake.

Some might read the vast public preoccupation with a broad set of social, political, and economic issues as the contamination of science with politics. But I would suggest that this is actually a case of the reverse problem: seemingly endless conflict around the AquAdvantage salmon reflects the limitation of using narrow scientific terms to address questions of broad social, political, and economic significance.

Scientists often dismiss resistance to the AquAdvantage salmon and other biotechnologies as borne of scientific ignorance. But its a lot easier to understand peoples reluctance if you realize that the debate is about much broader questions than science alone can answer.

Read the original post:
Are you 'anti-science' if you resist biotechnology on political or economic grounds? - Genetic Literacy Project

Bioengineering graduate takes off at Rocket Lab | Scoop News – Scoop.co.nz (press release)

Bioengineering graduate takes off at Rocket Lab

When Alex Anderson was a teenager growing up in Waiuku, he read a lot of science fiction and dreamt of one day building futuristic things like robots.

Today Alex has arguably done even better than that. The 30-year-old Mt Eden resident who graduates from the University of Aucklands Bioengineering Institute with a PhD in Biomedical Engineering, is now building rockets for a living.

Its a dream job, he says of his role with Rocket Lab.

Rocket Lab is a US company with a base of operations in New Zealand.

They are developing launch vehicles to put small satellites into space, explains Alex. These satellites traditionally have to compromise on orbit to ride share with larger satellites.

Rocket Labs Electron will lower the barrier to commercial space by offering frequent and cheap launches direct to orbit from the Mahia Peninsula on the North Islands East Coast.

Alex is a vehicle test engineer with Rocket Lab and says his role involves testing all the various components and systems which make up a launch vehicle and feeding the results of those tests back to the designers.

He has drawn on his general engineering background in instrumentation and electronics, as well as the training hes received in scientific method (for example striving for rigorous tests) to do his job.

Alex is a good example of how transferrable Bioengineering skills can be to a broad range of industries and applications, says his PhD supervisor Associate Professor Andrew Taberner.

For his PhD, Alex developed a new scientific instrument for studying tissue extracted from a living heart. In this device, a pulse of electricity causes calcium ions to be released into living muscle cells. This stimulates the cells to shorten, change shape, release heat and perform work.

Alex's instrument is the first to allow all of these events to be observed together, says Associate Professor Taberner. It will enable a deeper study of the relationships between the systems driving the heart, in health and disease.

https://www.rocketlabusa.com

http://www.abi.auckland.ac.nz/

http://www.abi.auckland.ac.nz/

Scoop Media

Read more here:
Bioengineering graduate takes off at Rocket Lab | Scoop News - Scoop.co.nz (press release)

Interview: Adam Piore And The Jaw-Dropping Science Of Bioengineering – WSHU

In his new book, The Body Builders: Inside the Science of the Engineered Human,author and award-winning journalist Adam Piore says the new frontier that intrigues scientists and engineers today is the human body.

He says amazing work and research is underway that melds technology with biology.These innovations can heal devastating injuries or even rewire the brain.

Piore tells us about this evolving science through the stories of the people who develop the technology and the people who are transformed by it.

Piore recently sat down with All Things Considered Host Bill Buchner. Below is a transcript of their conversation.

You are a journalist by profession, a foreign correspondent at one point.So how did you come to write this book?

I covered a lot of things, I covered Congress, I lived in Cambodia, and I went to Iraq, but one of the things that has always intrigued me in my journalism is stories of human resilience.Its always fascinated me how people overcome adversity and are able to live with setbacks.

So a few years ago I came across the story of an incredible scientist named Hugh Herr.And his story so fascinated me that I sort of followed along that path and went sort of down the rabbit hole into these new technologies bioengineering which are unleashing untapped resilience in the human body.I found that the most exciting stories of human resilience in the United States are often being unleashed by these biotechnologies.

Speaking of Hugh Herr, he survived a rock climbing incident that led him to develop more advanced forms of prosthetic legs that he calls wearable robots. Would you tell us about that?

Hugh had a really remarkable story.He was not that great a student when he was a teenager, he was a C and D student, but he lived to rock climb and he was a nationally known athlete, one of the best up and coming rock climbers in the country.He went ice climbing with a friend in New Hampshires Mount Washington.They got stuck in a blizzard and they wandered into the wilderness, and they got lost and they almost died.They were saved at the last moment but not in time to save them completely.They both had frostbite and Hughs legs were amputated below the knees.

And the doctors told him he would never run or climb again.And every day, he would wake up dreaming that he was running through the cornfields behind his house, and then hed wake up and his legs would be gone.But he didnt stay in bed very long. He began tinkering with his prosthetics and he was back on the climbing wall. And he made them seven-feet long and he made blades that he could slip into crevices.And he became an even better rock climber than he had been before.

And this tinkering sort of led him to tinker when he was down on the ground because his prosthetics were so uncomfortable.He began taking engineering classes.And flash forward 20 or 30 years, hes one of the leading bioengineers and prosthetic engineers in the world.Hes at MIT.And he has designed these bionic limbs that really kind of show whats possible, that allow him to walk again.

Pat Fletcher is featured in the part of your book where you explore how bionics can enhance our senses.Fletcher survived an industrial accident which left her blind. Twenty-five years later, she was able to use new technology that allowed her to see with her ears.How likely are we to see more Pat Fletchers out there with this type of technology?

Where Hugh just wanted to climb and run, Pat loved nature and she was blinded in a grenade factory explosion and could no longer see and years later she is seeing mountains again.Its an example of the incredible plasticity of the human mind.What she discovered online was this device that was created by this Dutch engineer, which they call a sensory substitution device and its based on this insight that we see with the brain and not the eyes.

If we can get the information from the outside world into our brain, its the worlds most sophisticated pattern recognition machine. What this device does is it takes the pixel in pictures and turns them into different tones, sort of like a wall of sound.Over time Pats brain learned to recognize these sounds and route them to her visual cortex. And she can actually make sense of the world. Shes regained depth perception. She can see the leaves on trees, she can see mountains.She can see the cracks on sidewalks.Its pretty remarkable.

Continued here:
Interview: Adam Piore And The Jaw-Dropping Science Of Bioengineering - WSHU

Students Inducted into Honor Society, Win Awards At American … – Wesleyan Connection (blog)


Wesleyan Connection (blog)
Students Inducted into Honor Society, Win Awards At American ...
Wesleyan Connection (blog)
Julianne Riggs '17 in Chicago last month, where she attended the American Society for Biochemistry and Molecular Biology meeting. Five Wesleyan seniors ...
Prebiotic Qualities of Dried Plums Identified as a Colon Cancer ...Oncology Nurse Advisor

all 2 news articles »

See the rest here:
Students Inducted into Honor Society, Win Awards At American ... - Wesleyan Connection (blog)

‘Grey’s Anatomy’ Star Jesse Williams Reportedly Left His Wife and Kids For Minka Kelly – Maxim


Maxim
'Grey's Anatomy' Star Jesse Williams Reportedly Left His Wife and Kids For Minka Kelly
Maxim
'Grey's Anatomy' Star Jesse Williams Reportedly Left His Wife and Kids For Minka Kelly. Damn, dude. Avatar: Author: Brandon Friederich; Publish date: a few seconds ago; Social count: 0. Damn, dude. 0. SHARES. 0; 0; 0; 0. GettyImages-112100008.
Greys Anatomy star Jesse Williams is still focused on his family despite the split from his estranged wifeRare.us
Jesse Williams divorce: He's moved out but has been visiting his kidsWonderwall
Jesse Williams Moving Out and Moving On But Still There for the KidsTMZ.com
Blasting News
all 17 news articles »

Link:
'Grey's Anatomy' Star Jesse Williams Reportedly Left His Wife and Kids For Minka Kelly - Maxim

Mother Makes Ultimate Sacrifice for Unborn Child on ABC’s Grey’s Anatomy – LifeNews.com

In a society where preborn children are treated as disposable property, and disregarded in the name of cold, sterile, euphemisms such as reproductive rights and choice, its rare to find a mother who actually does the opposite of putting herself above her child.

But in April 27ths episode of Greys Anatomy on ABC, we got to see that rarity played out in a heart-wrenching yet inspiring storyline.

Patient Veronica is in the ER at Grey-Sloan Memorial Hospital for back pain. Shes almost 35 weeks pregnant and her body is riddled with cancer. She decided to forgo cancer treatment because, as she put it, I didnt want to microwave the baby.

The storyline is a continuation from earlier this season when Veronica refused to abort her baby despite pressure from Doctor Miranda Bailey (Chandra Wilson) to kill her child to begin treatments for her terminal pancreatic cancer. (See previous article for factual information on cancer during pregnancy as well, as this episode did not accurately reflect the truth on the effects of chemotherapy and radiation on a preborn baby.)

The prognosis isnt good, as was expected, and as Veronica planned for. The doctors give her two months at best left to live, as the cancer has spread even further and is compressing her spinal cord. And they tell her that they must deliver the baby that day.

Follow LifeNews.com on Instagram for pro-life pictures.

All right. Lets cheer up, everybody. Were having a baby, Veronica announces optimistically, looking forward to having two months to spend with her baby and the babys father.

But during the C-section, things take a turn for the worst:

Amelia: Heart rates up to 130. Veronica, hows yourbreathing?

Veronica: Its fi um, its a little tough.

Jeremy: Whats happening? Whats going on?

Veronica: Hey, Jer, come on. Look at him.He has the sweetest eyes.

Arizona: Her sats are dropping. Shes persistentlytachycardic.

Amelia: Lets put her back on high-flow oxygen.It could be an embolus.

Veronica: Time to get him out of here.

Alex: Yeah, in a minute.

Arizona: If its an embolus, we dont have a minute.

Alex: She did all this so she can meet the baby.Just give them another damn minute.

Veronica: Jer, can you take him?

Alex: He needs to go to the NICU now.

Jeremy: And, uh, what what about Veronica?

Alex: Shes in good hands. Shell be just fine.Ill take good care of her.

Veronica: Jer, you stay with him.You promised. Im counting on you.

Jeremy: But I dont

Veronica: Go on. Stay with him.Ill see you in a little bit.

Amelia: Are we pushing heparin or going straightto thrombolytics?

Arizona: Thrombolytics are contraindicated.We need to do an embolectomy, and lets getan ivc filter.

Amelia: Veronica, youve thrown a blood clot,and its traveled all the way to your lungs.Its very serious. We need to remove it immediately,so were gonna need to put you under andopen up your chest.

Veronica: Is thatUhUh, will that work?

Amelia: The procedure will only last about a halfan hour.

Veronica: Will it work?

Amelia: Theres no guarantee youd survive it.

Veronica: And what if we didnt do anything?

Arizona: Veronica, we need to do this procedure.If we dont, you might not make it off thistable today.

Amelia: Okay, pressures dropping. Get a cart ready!

Veronica: No. I signed that dnr for a reason.

Arizona: You can rescind. Let us help you.

Veronica: I did what I wanted. My babysokay.It Im so tired.

Amelia: I know.I know.

Too bad Dr. Miranda Bailey wasnt around to see that beautiful baby alive and well thanks to his mother not listening to her pro-abortive advice.

Later, we see Veronica in her last moments and realize even further what an amazing mother she was to give up her own life for her childs:

Amelia: What do you want? What do you needright now?

Veronica: Im so cold.

Amelia: Ill get a warming blanket.

Veronica: No! No.Can you Will you just hold me?We did good?The babys good?

Amelia: Babys good.

Yes, Veronica, you did good. And your baby is so very good because of your beautiful sacrifice.

LifeNews Note: Dawn Slusher writes for Newsbusters, where this originally appeared.

Original post:
Mother Makes Ultimate Sacrifice for Unborn Child on ABC's Grey's Anatomy - LifeNews.com

Scoop: GREY’S ANATOMY on ABC – Thursday, May 18, 2017 – Broadway World

On the episode Ring of Fire, the doctors lives are at risk after a dangerous patient escapes the hospital room. Alex must make a hard choice in his relationship with Jo while Meredith has some big news for Nathan that brings things to a turning point, on the season finale of Greys Anatomy, THURSDAY, MAY 18 (8:00-9:01 p.m. EDT), on The ABC Television Network.

Greys Anatomy stars Ellen Pompeo as Meredith Grey, Justin Chambers as Alex Karev, Chandra Wilson as Miranda Bailey, James Pickens Jr. as Richard Webber, Kevin McKidd as Owen Hunt, Jessica Capshaw as Arizona Robbins, Jesse Williams as Jackson Avery, Sarah Drew as April Kepner, Caterina Scorsone as Amelia Shepherd, Camilla Luddington as Jo Wilson, Jerrika Hinton as Stephanie Edwards, Kelly McCreary as Maggie Pierce, Jason George as Ben Warren, Martin Henderson as Nathan Riggs and Giacomo Gianniotti as Andrew DeLuca.

Greys Anatomy was created and is executive produced by Shonda Rhimes (Scandal, How to Get Away with Murder), Betsy Beers (Scandal, How to Get Away with Murder) and Mark Gordon (Saving Private Ryan). William Harper, Stacy McKee, Zoanne Clack and Debbie Allen are executive producers. Greys Anatomy is produced by ABC Studios.

Guest Starring are Debbie Allen as Catherine Avery and Marika Dominczyk as Eliza Minnick.

Ring of Fire was written by Stacy McKee and directed by Debbie Allen.

Greys Anatomy is broadcasted in 720 Progressive (720P), ABCs selected HTV format, with 5.1-channel surround sound.

View post:
Scoop: GREY'S ANATOMY on ABC - Thursday, May 18, 2017 - Broadway World

Anatomy of a Goal: Jack Harrison’s Game Winner – Massive Report

Welcome to Anatomy of a Goal, where each week we dissect one goal from the previous weeks Columbus Crew SC match.

For Week 9 of the 2017 MLS season, we take a look at Jack Harrisons 76th minute goal that gave New York City FC a 3-2 lead as part of their win over Crew SC on Saturday.

Heres a look at the finish from the NYCFC winger.

Crew SC were on the back foot for much of second half of Saturdays match. Columbus manger Gregg Berhalter admitted as much after the match, suggesting that the Black & Gold lost complete control of the match after taking a second half lead.

Berhalter said #CrewSC lost complete control of the match after taking the lead early in the second half.

NYCFCs game winner began with an Alexander Callens long-ball to winger Rodney Wallace. In the above image, note the Crew SC pressure forcing the NYCFC center back to play a 50/50 ball into the Columbus defensive half. Black & Gold midfielder Mohammed Abu likely should have been covering someone in the middle of the field, but he does begin to track back to his defensive half as he sees Callens make the deep pass.

Wallace receives the ball in a difficult position, and attempts to flick the ball into the path of City striker Sean Okoli. Jonathan Mensah is well positioned to defend this pass, and easily beats Okoli to the ball.

On the far right side of the above image, just to the right of the referee, you can just see Yangel Herrera, who will have the assist on Harrisons goal. Abu is just behind Herrera.

As Jonathan approaches the ball he has three options: a drop pass to goalkeeper Zack Steffen who has a full view of the field, a square pass to right back Harrison Afful or kick the ball way over the head of Afful and out of bounds letting Crew SC regroup defensively. A pass to Steffen is probably the worst option, but any of these three choices should have given his side a chance to move the ball back up the field.

Jonathan opts to make the easy pass to Afful, who will immediately be pressed by Wallace. Both Wallace and Okoli were prepared to pressure the Crew SC back line as soon as the ball was turned over, and that press will force Afful to make a quick decision.

As Afful prepares to receive the ball, he has four immediate options: a drop pass to Steffen, a pass back up the field to Wil Trapp (just to the right of this image), a pass to center-back Nikolai Naess, splitting Okoli and Wallace or a pass back to Jonathan if he moves into a better position.

A pass to Trapp, who was unmarked, would have been ideal but was likely just out of Affuls view and made for a difficult option under the pressure of Wallace.

Before we move on, pay attention to the huge space between the back line and the Crew SC midfielders. From this view, you cant even see Abu or Trapp, though Trapp gets to the sideline in time to theoretically receive a pass. Though Abu began tracking back, he isnt able to make himself useful in this play, showing the value injured Artur with his ability to cover acres of space.

Wallace closes down Affuls angle to the sideline and Okoli pressures Jonathan, removing two of the right backs passing options. Jonathan takes his run in the path of Steffen, effectively bringing Okoli into the path of Steffen as well, further limiting Affuls passing options.

With only one real option to choose from, Afful elects to make a seemingly difficult pass to Naess in the middle of the field. Afful likely sees Naess, highlighted on the right side of the image, and is likely unable to see Herrera sprinting downfield (Editors note, this was confirmed by Afful postgame). From Naesss reaction to Affuls pass, he also did not notice the NYCFC midfielder heading his way.

From this angle, Affuls pass to Naess looks slightly less difficult than the previous view. Wallace may just be cutting off Affuls vision of the right side of the field, hiding the sprinting Herrera from view.

Now is when things really start to go downhill for the Black & Gold. Somehow, Naess did not noticed Herrera blazing toward the ball. Judging by Naesss nonchalant jog toward the ball, it doesnt seem like anyone tells him that Herrera is bearing down on him. Abu still hasnt been able to get in front of Herrera, and will soon slow to a jog and fully give up on this play.

Had Naess not switched off, he would have had a very easy one-touch pass to a totally unmarked Trapp.

Herrera is able to get to the ball at the same time as the Crew SC center back. As you will see below, Herrera is able to deflect the ball around Naess to set up his assist to Harrison. Abu has totally slowed up, and spends the rest of the play doing little more than halfheartedly jogging toward the goal.

In the video above, you can see just how blindsided Naess was by Herrera. I wasnt able to hear what was happening on the field, but if the team is communicating as it should have been (i.e. Steffen and Abu both yelling to Naess about the impending collision with Herrera), then this goal should not have happened.

Once Herrera has deflected the ball around Naess, he sets off a footrace to the ball with the Crew SC defender. Finally, Harrison has arrived on the scene running totally unmarked into the Crew SC goal box. Harrison was able to catch Columbus left back Jukka Raitala too far up the field, and easily beats him back into the attack.

As Herrera beats Naess to the ball, he has a very simple pass to Harrison, who remains unmarked. Raitala has closed down the distance to Harrison, but will be unable to catch the NYCFC winger.

Naess is able to make Herreras pass more difficult than initially anticipated, forcing the City midfielder to make a sliding pass into the path of his teammate. Raitala continues to close down Harrison, but the speedy winger will just beat Raitala and Naess to the ball.

To Raitalas credit, he nearly catches Harrison before he can slot the ball between Steffens legs. Still, neither Raitala nor Naess are able to get in front of Harrisons shot.

Notice Steffens positioning. He has made himself wide in front of Harrison, but his legs are spread very far apart, giving Harrison an easy path to goal.

Note the above video to see just how open Harrison was. Even though Harrison had to slow down his run he still gets to the ball before anyone from Crew SC.

Not the best look for Steffen in the image above. The Crew SC goalkeeper, who had already been chipped for Harrisons first goal, gets nutmegged for the game winner.

Findings:

View post:
Anatomy of a Goal: Jack Harrison's Game Winner - Massive Report

Triggering Stem Cells for Accelerated Healing – Anti Aging News

Recent research, led by assistant professor of stem cell biology and regenerative medicine at the University of South Carolina Joseph T. Rodgers, has found a way to increase the bodys ability to heal after injury. The study was published in the scientific journal Cell Reports.

The research was funded by grants from the National Institutes of Health. Funding was also secured from the Donald E. and Delia B. Baxter Foundation, Glenn Foundation for Medical Research, and the Department of Veterans Affairs. The study was co-sponsored by the Department of Neurology and Neurological Sciences at Stanford. Clinical Research

In previous research, Rodgers proved that adult stem cells enter an alert state when the body sustains an injury. Alert stem cells have greater ability to heal and repair damaged tissues.

Rodgers theorized that blood from an injured person could produce a state of alert in another persons stem cells. Using lab mice, he and his team injected healthy mice with blood from their injured counterparts. The stem cells of the healthy mice were observed to adopt the state of alert.

The team was able to expose the chemical mechanism used to signal cells to enter an alert state as the enzyme Hepatocyte Growth Factor Activator (HGFA). HGFA is always present in the bloodstream but does not activate until the body experiences an injury. Once an injury occurs, the enzyme signals adult stem cells to enter the alert state.

Implications for Repair Response in the Injured Body

Once these findings were discovered, Rodgers team decided to investigate what would happen if an injury was sustained while the adult stem cells were already in a state of alert.

HGFA was injected into healthy mice. Several days later, the mice were given skin or muscle injuries. Test subjects were observed to heal faster, regrow missing fur, and return to running on exercise wheels sooner.

This research supports the idea that the presence of HGFA in the bloodstream prepares the body to respond more quickly and efficiently to injury. Similar to the way vaccines prepare the body to fight specific diseases, HGFA readies cells to respond to tissue damage.

Future Applications

In the future, people may be able to use HGFA before they engage in activities that could result in injury, like sports, surgery, or battle. HGFA could also be used in a therapeutic capacity for those with compromised healing abilities, like diabetes patients or senior citizens.

Forthcoming studies will explore how HGFA affects declines in the ability to heal, and how to use it to restore normal healing abilities.

Read the original here:
Triggering Stem Cells for Accelerated Healing - Anti Aging News

Subscribe to Print: – Reader's Digest

For caucasians, it's wrinkles and age spots

Juta/Shutterstock"My caucasian patients tend to commonly present in their early 30s with wrinklesparticularly around the eyes or glabella (between the eyebrows)," says board certified dermatologist Manjula Jegasothy, MD, founder of Miami Skin Institute, who has been treating ethnically diverse patients for 20 years. "This is easily treated with Botox in the 30s and early 40s." She also suggests adding light radiofrequency treatments in the mid to late 40s to help with thin skin laxity in the upper face. Sun damageresulting in brown spots and blotchinessis another common complaint. She suggests getting a jump start in the early 20s and 30s with pyruvic, salicylic, and glycolic acid peels. Try: Dr. Dennis Gross Skincare Alpha Beta Universal Daily Peel and BeautyRx by Dr. Schultz Advanced 10% Exfoliating Pads. Patients in their late 30s and olderand those with more severe damageshould consider in-office IPL photofacials. This is how your skin ages through every decade of your life.

Click-Images/ShutterstockThe majority of Dr. Jegasothy's patients are Latina, and the culture is very focused on body image. "I find that these patients are much more focused on non-surgical treatment of scars," Dr. Jegasothy says. For best results, scars should be treated as soon as possiblewithin the first two years; ideally as early as three weeks after the incision has healedwith a combination of Vbeam and Fraxel laser. Since Miami is a city with warm temperatures year round, her Latin American patients tend to be more concerned with skin laxity issues and celluliteparticularly on the thighs and buttocks, the areas that show in shorts. For both of these issues, Dr. Jegasothy recommends radiofrequency treatments with the Viora laser. Ever wondered why is cellulite so dang hard to get rid of?

Content continues below ad

Dragon-Images/Shutterstock"My AsianChinese, Japanese, and Koreanpatients are interesting because they are very concerned with trying to become an idealized version of a caucasian with features common in the Asian press," says Dr. Jegasothy. As such, the most common Botox procedure she performs on her Asian patients is softening the jawline muscle to create a more oval or round appearance. Another common beauty request of her Asian patients is for their facial skin to be as fair as possible. To this end, she does skin lightening chemical peels and topical herbal agents, such as SkinMedica Lytera 2.0 Pigment Correcting Serum as often as possible."

Prostock-studio/Shutterstock"I have been treating Indian patients for over 20 years, and by far the most common complaint is excessive hair on the face and body," notes Dr. Jegasothy. She stresses the importance of using the correct lasers and settings for the various skin tones, since those that are too strong can cause hyperpigmentation that can persist for up to a year. Her preference is the Candela GentleYag Laser. (Don't miss the 14 things you need to know before you get laser hair removal.) The second most common issue is dark under-eye circles. When patients are young, this can be successfully treated with mild cortisone creams and peptide eye creams, such as Neocutis Micro-Eyes. "As patients age, if they have hollowing along the orbital bone (which is the lower eyelid rim), and filler can make the under-eye circle seem less prominent." More often however, she finds that light Fraxel treatments (repeated every four to 12 months, depending on severity, genetics and age), can improve this situation enormously. These are the secrets to aging gracefully.

sruilk/ShutterstockAccording to Dr. Jegasothy, Middle Eastern patients primarily have the same issues as Indian patients: excess hair at an early age and dark under eye circles, which are treated in the same fashion. "In addition, Middle Eastern mores dictate that patients have a certain eyebrow type, which is quite plucked at an early age. As the trend today is toward fuller brows, I'm seeing more Middle Eastern patients in early to middle age who are looking for more eyebrow hair." For this, she recommends Latisse, a topical hair-growth serum available by prescription. Find out the best brows for your face shape.

Content continues below ad

Continued here:
Subscribe to Print: - Reader's Digest

Using art to explain chemistry, NVC professor writes and illustrates his own book – Napa Valley Register

Dr. Steven Fawls lifelong journey from wanting to do chemistry at the age of 7 to writing the definitive college chemistry textbook at age 62, is the stuff of legend.

After teaching chemistry for nearly 40 years, including 32 at Napa Valley College, Fawl decided that it was about time that he put his years of experience down on paper.

To that end, he wrote an 800-page textbook. It took just three years to write, a feat that takes most authors 10 years or more to accomplish.

What makes the text notable is that he not only wrote the words but he also created all of the artwork. He drew nearly 2,000 images and graphics, including some that have never before been seen or conceived in any previous textbook.

The book, Insights in Chemistry, is receiving rave reviews from college chemistry educators who say Fawl is breaking new ground in a subject that has been around for approximately 24 centuries.

Fawl is already putting together a more concise, and even more graphically appealing, revised edition, due to be published in August.

I like chemistry because it answers the question, Why? said Fawl, who said he acquired an appreciation of art from his mother and a passion for writing from his father.

Fawl always had an aptitude for math and science but also had a strong interest in art.

In his senior year of high school he received a full-ride scholarship to art school, but turned it down in order to study chemistry.

I remember sitting down with my father to discuss my choices. He told me that if I went into chemistry, that I could still do my art, so now I do both.

So, throughout his teaching career Fawl has used art to explain chemistry.

There are topics in chemistry where we tell students that something happens and we never tell them why, he said.

Most of the time this happens because neither the books nor the instructors understand the topic well enough to explain it themselves. But when you use art, chemistry becomes real.

Through my art I have created images of things that have never been seen before. You understand it when you see it, and I have discovered ways of explaining these concepts through my art.

While his publisher had been happy to print several of Fawls lab manuals, more was expected of the longtime educator.

They asked me if I was working on anything else that might interest them and I told them that I had written the beginning of a chemistry textbook. They told me that they couldnt afford to publish a chemistry book because of the cost of the artwork. I smiled and told them, But I am going to do all the artwork, and they gave me the go-ahead.

As a result, I have created many images that have never been seen before and in some cases never conceived before. I am lucky because I dont have to depend on someone else to interpret my words in order to draw my pictures. I draw exactly what I see in my mind. If I hadnt been an artist, my students would never have seen the most important images in my book.

Through his art, Fawl has achieved an unprecedented insight into subjects that most instructors do not understand, especially in the area of quantum mechanics.

Quantum mechanics is hard, Fawl explains, but not because the topic is that difficult, I just think that it is taught poorly. For example, most instructors have little or no understanding of the shapes of atomic orbitals, but in my book, I explain exactly how and why these shapes are made.

This past year, Fawl was asked to give a presentation to a group of students who teach in NVCs Supplemental Instructor program.

Using his art background, Fawl gave these students jars of Play-Doh and some kitchen knives and a simple set of rules.

Following those rules, the students were able to create accurate 3D models of atomic orbitals that have never been drawn in any book. The technique is said to be groundbreaking.

Richard Thompson-Bremer, Emeritus Professor of English at NVC and one of Fawls mentors, complemented Fawl for writing a chemistry book that even he could understand.

The book has revelatory 3-D images, said Bremer.

Dr. Fawl offers leading-edge thinking, presenting concepts and methods not addressed in prior textbooks. His students are privileged to learn with a mentor who models critical and creative thinking.

Dr. Steven Farmer, chemistry professor at Sonoma State University, agreed.

This is easily the most proficient teaching textbook Ive ever seen, said Farmer. It contains several new methods for explaining general chemistry concepts.

NVC chemistry professor Josh Hanson said his students are reading the textbook because they enjoy it.

They can just open it up and start reading and learning, said Hanson, who taught at Woodland College, Cosumnes River College and UC Davis before coming to NVC this year.

The book presents an alternate way of looking at things, different than the way I learned and taught chemistry. I come from a different background, so its interesting to see students doing something I never taught them, and doing it well.

Hanson said he would not be surprised to see other college chemistry programs using the book.

I would like to see the book in more places because it is instructional instead of encyclopedic. Steve has a background in art and he uses that in his chemistry, Hanson said.

One of Fawls former students, Dr. Robert Cattolica, biology instructor at Chabot College, credits his academic and professional success to Fawls rigorous academic standards, coupled with highly effective and engaging teaching techniques.

Several of Fawls students, after they completed the chemistry series at Napa Valley College, moved on to UC Davis. Some, like James Carter, became tutors there.

Under Dr. Fawls apprenticeship I fell in love with chemistry, said Carter, who is studying for his doctorate at UNLV. When he applied to Davis, he wanted to become a tutor in organic chemistry but the school was reluctant to accept a community college as a prerequisite, said Carter.

They were not certain that any community college would be comparable or adequate, so they required me to take a placement exam. When I scored over the 90th percentile, they told me my education was good enough, and they offered me a position as an instructional aide, a tutor, doing academic workshops.

Go here to see the original:
Using art to explain chemistry, NVC professor writes and illustrates his own book - Napa Valley Register

Puma Biotechnology Inc (PBYI) Expected to Announce Earnings of … – The Cerbat Gem


Post Analyst

Continue reading here:
Puma Biotechnology Inc (PBYI) Expected to Announce Earnings of ... - The Cerbat Gem

Subscribe to Print: – Reader’s Digest

For caucasians, it's wrinkles and age spots

Juta/Shutterstock"My caucasian patients tend to commonly present in their early 30s with wrinklesparticularly around the eyes or glabella (between the eyebrows)," says board certified dermatologist Manjula Jegasothy, MD, founder of Miami Skin Institute, who has been treating ethnically diverse patients for 20 years. "This is easily treated with Botox in the 30s and early 40s." She also suggests adding light radiofrequency treatments in the mid to late 40s to help with thin skin laxity in the upper face. Sun damageresulting in brown spots and blotchinessis another common complaint. She suggests getting a jump start in the early 20s and 30s with pyruvic, salicylic, and glycolic acid peels. Try: Dr. Dennis Gross Skincare Alpha Beta Universal Daily Peel and BeautyRx by Dr. Schultz Advanced 10% Exfoliating Pads. Patients in their late 30s and olderand those with more severe damageshould consider in-office IPL photofacials. This is how your skin ages through every decade of your life.

Click-Images/ShutterstockThe majority of Dr. Jegasothy's patients are Latina, and the culture is very focused on body image. "I find that these patients are much more focused on non-surgical treatment of scars," Dr. Jegasothy says. For best results, scars should be treated as soon as possiblewithin the first two years; ideally as early as three weeks after the incision has healedwith a combination of Vbeam and Fraxel laser. Since Miami is a city with warm temperatures year round, her Latin American patients tend to be more concerned with skin laxity issues and celluliteparticularly on the thighs and buttocks, the areas that show in shorts. For both of these issues, Dr. Jegasothy recommends radiofrequency treatments with the Viora laser. Ever wondered why is cellulite so dang hard to get rid of?

Content continues below ad

Dragon-Images/Shutterstock"My AsianChinese, Japanese, and Koreanpatients are interesting because they are very concerned with trying to become an idealized version of a caucasian with features common in the Asian press," says Dr. Jegasothy. As such, the most common Botox procedure she performs on her Asian patients is softening the jawline muscle to create a more oval or round appearance. Another common beauty request of her Asian patients is for their facial skin to be as fair as possible. To this end, she does skin lightening chemical peels and topical herbal agents, such as SkinMedica Lytera 2.0 Pigment Correcting Serum as often as possible."

Prostock-studio/Shutterstock"I have been treating Indian patients for over 20 years, and by far the most common complaint is excessive hair on the face and body," notes Dr. Jegasothy. She stresses the importance of using the correct lasers and settings for the various skin tones, since those that are too strong can cause hyperpigmentation that can persist for up to a year. Her preference is the Candela GentleYag Laser. (Don't miss the 14 things you need to know before you get laser hair removal.) The second most common issue is dark under-eye circles. When patients are young, this can be successfully treated with mild cortisone creams and peptide eye creams, such as Neocutis Micro-Eyes. "As patients age, if they have hollowing along the orbital bone (which is the lower eyelid rim), and filler can make the under-eye circle seem less prominent." More often however, she finds that light Fraxel treatments (repeated every four to 12 months, depending on severity, genetics and age), can improve this situation enormously. These are the secrets to aging gracefully.

sruilk/ShutterstockAccording to Dr. Jegasothy, Middle Eastern patients primarily have the same issues as Indian patients: excess hair at an early age and dark under eye circles, which are treated in the same fashion. "In addition, Middle Eastern mores dictate that patients have a certain eyebrow type, which is quite plucked at an early age. As the trend today is toward fuller brows, I'm seeing more Middle Eastern patients in early to middle age who are looking for more eyebrow hair." For this, she recommends Latisse, a topical hair-growth serum available by prescription. Find out the best brows for your face shape.

Content continues below ad

Read more:
Subscribe to Print: - Reader's Digest

Hermann Wellness of Tampa and St. Petersburg Launches Newly Designed Website – MENAFN.COM

(MENAFN Editorial) Hermann Wellness, an anti-aging treatment medical spa with locations in Tampa and St. Petersburg, recently launched its newly redesigned and restructured website at http://doctorhermann.com.

Hermann Wellness, led by Dr. Anne Hermann, M.D., provides the best and most comprehensive aesthetic medicine services in the Tampa Bay area. It is Dr. Hermann's mission to enable each of her patients to achieve optimal health by combining cutting edge technology and the latest research with compassionate medical care. Now, Hermann Wellness offers visitors and patients an updated and redesigned website for an enhanced browsing experience.

The newly designed Hermann Wellness website, found at http://doctorhermann.com, offers users a comprehensive menu with detailed information about each of the more than 50 services that Dr. Hermann has to offer. This interactive site also offers informative videos from Dr. Hermann herself, an online scheduling tool, and reviews from past patients. Overall, the new design and fresh content highlight the true impact that Dr. Hermann and her team can make to improve her patient's overall health offering treatments that address overall wellness and beauty from the inside out.

Dr. Hermann has more than 17 years of experience in internal, holistic, and cosmetic medicine. She obtained her Board Certification in Internal Medicine in 2000, then trained as a medical acupuncturist at UCLA Medical School and Professional Hypnologist at the Cord Institute of Hypnosis in 2004. Dr. Hermann also became Board Certified as a Physician Nutrition Specialist in 2004. Since then, she has completed advanced training in botox, dermal fillers, and other cosmetic procedures, and she has continued to grow her expertise within the holistic approach to medicine.

With two locations in Tampa and St. Petersburg, Hermann Wellness is conveniently located for all patients seeking customized care for aesthetic treatments, weight loss services, integrative medicine, and much more. Dr. Hermann's extensive training and experience in aesthetics and weight loss has made Hermann Wellness Tampa Bay's leader in cosmetic services and physician assisted weight loss and nutrition.

Anti-aging PRP injections, dermal fillers, and micro-needling skin resurfacing to the Optifast weight loss plan and Detox Diet, Hermann Wellness offers all of the essential services that help patients achieve the health and confidence they have always wanted.

Members of the community or media interested in learning more about Hermann Wellness and its newly designed website are invited to use the following contact information:

NAME: Dr. Anne Hermann, M.D. ADDRESS: 3040 W. Cypress St., Suite 103, Tampa, FL 33609 or 6387 Central Ave, St. Petersburg, FL 33710 PHONE: (813) 902-9559 (Tampa) or (727) 278-3992 (St. Petersburg) WEBSITE: http://doctorhermann.com EMAIL:

Go here to see the original:
Hermann Wellness of Tampa and St. Petersburg Launches Newly Designed Website - MENAFN.COM